CVS Health Action: Erneuter Kursrückgang trotz solider Fundamentaldaten ()

The CVS Health Aktie is verzeichnete on August 27 a fee of 1.94% on 51.49 EUR. If the negative trend occurs in the direction of the negative trend – on Monday the negative interest rate is 6.15%. Dennoch is on the course with 5.22% on the 52-Wochen-Tief, but furthermore deutlich below the Jahreshoch.

The confidence in the US dollar is that the fundamentals of the US healthcare sector are solid again. In 2024 there was a KGV of 8.96 which had a big reward. Even the expected dividend payout of 4.18% for the annual success is attractive. The short-term return ratio is 0.29 ebenfalls in the low range.

Ausblick bleibt herausfordernd

Analysts see CVS Health facing challenges due to rising healthcare costs and insurance. The integration of digital technology and the costs associated with external solutions are possible. The difference is how CVS Health can adapt its business model and evolving market conditions.

Display

CVS Health promotion: Buy or sell?! New CVS Health Analysis from 27. August loves Antwort:

The current CVS Health treatments tell a clear story: lung disease for CVS Health business. Want to make a purchase or another purchase? In the free analysis of August 27th, it was time.

CVS Health: Buy or sell? Read more here…